News & Updates
Filter by Specialty:
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
byJairia Dela Cruz
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.